Elanco Animal Health Inc (ELAN)

HEALTH CARE: HEALTH CARE SERVICES
SIC: PHARMACEUTICAL PREPARATIONS

2500 INNOVATION WAY GREENFIELD, IN 46140

Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide.

Data as of 2020-07-04
Market Cap8.461 Billion Shares Outstanding398.894 Million Avg 30-day Volume4.602 Million
P/E Ratio Dividend Yield EPS-0.02
Price/Sales3.818 Price cash flow ratio36.5 Price free cash flow ratio-160.7
Book Value16.7 Price to Tangible Book7.03 Alpha
Short Interest Ratio2.43 % Short Interest to Float3.1 R-squared
BETA 52-week High/Low35.23 / 15.17 Stddev

Are you looking for this stock instead?

View SEC Filings from ELAN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 4 3 (0.2%)
13F Filers holding this stock: 355 85 (5.57%)
Aggregate 13F shares on 03/31/2020: 397.483 Million 120.8 Million
Aggregate 13F shares on 12/31/2019: 369.386 Million 127.488 Million
Percent change: 7.61% -5.25%
Funds creating new positions: 61 29
Funds Adding to an existing position: 162 29
Funds closing out their position: 83 34
Funds reducing their position: 91 18
Heat Map Ranking for 03/31/2020 312
Heat Map Ranking for 12/31/2019 28
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ELAN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ELAN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BILBREY JOHN P

  • Director
21,152 2020-07-01 3

MASON RACQUEL HARRIS SEE REMARKS

  • Officer
21,237 2020-07-01 2

CORREIA DE SIMAS JOSE MANUEL SEE REMARKS

  • Officer
15,102 2020-07-01 2

GARCIA ART A

  • Director
0 2020-06-30 1

ANAND KAPILA K

  • Director
13,676 2020-06-11 2

MEER JAMES M CHIEF ACCOUNTING OFFICER

  • Officer
7,917 2020-06-03 3

KOCHEVAR DEBORAH TURNER

  • Director
9,047 2020-05-11 2

KURZIUS LAWRENCE ERIK CHAIRMAN, PRESIDENT & CEO

  • Officer
  • Director
112,178 2020-04-01 1

HOOVER R DAVID

  • Director
76,995 2020-03-13 4

HARRINGTON MICHAEL J

  • Director
16,799 2020-03-09 2

HICKS MICHAEL-BRYANT SEE REMARKS

  • Officer
42,137 2020-03-01 2

YOUNG TODD S. SEE REMARKS

  • Officer
41,513 2020-03-01 3

SIMMONS JEFFREY N PRESIDENT, CEO & DIRECTOR

  • Officer
  • Director
489,117 2020-03-01 5

URBANEK DAVID ALAN SEE REMARKS

  • Officer
67,640 2020-03-01 4

CABRAL RAMIRO MARTIN SEE REMARKS

  • Officer
44,771 2020-03-01 3

SCHACHT AARON L SEE REMARKS

  • Officer
66,727 2020-03-01 3

KINARD DAVID S SEE REMARKS

  • Officer
67,466 2020-03-01 3

LIN SARENA S SEE REMARKS

  • Officer
66,051 2020-03-01 2

MCDONALD KIRK P

  • Director
8,016 2019-11-29 1

SCOTS-KNIGHT DENISE

  • Director
8,016 2019-11-29 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CORREIA DE SIMAS JOSE MANUEL - Officer SEE REMARKS

2020-07-01 A 15,102 a 15,102 15,102.00 direct

MASON RACQUEL HARRIS - Officer SEE REMARKS

2020-07-01 A 21,237 a 21,237 21,237.00 direct

MEER JAMES M - Officer CHIEF ACCOUNTING OFFICER

2020-06-03 F 71 $22.93 d 7,917 7,917.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments